QUIT for Smoking, Cigarette

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Smoking, Cigarette+11 More
QUIT - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing a cognitive-behavioral-based intervention to help smokers living with HIV quit smoking by reducing anxiety and depression.

Eligible Conditions
  • Smoking, Cigarette
  • Anxiety
  • Smoking
  • Smoking, Cessation
  • Nicotine Dependence
  • Depression
  • HIV

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: Time frame: 6-Month Follow-Up (approximately 6-months post quit date)

Time frame: 1-Month Follow-Up (end of treatment/approximately 1-month post quit date)
Short-Term Point Prevalence Smoking Abstinence
Time frame: 6-Month Follow-Up (approximately 6-months post quit date)
Long-Term Point Prevalence Smoking Abstinence

Trial Safety

Trial Design

3 Treatment Groups

Standard of Care
1 of 3
Time and Intensity-Match Control
1 of 3
QUIT Treatment for Smoking Cessation and Distress Tolerance
1 of 3
Active Control
Experimental Treatment

360 Total Participants · 3 Treatment Groups

Primary Treatment: QUIT · No Placebo Group · N/A

QUIT Treatment for Smoking Cessation and Distress Tolerance
Behavioral
Experimental Group · 1 Intervention: QUIT · Intervention Types: Behavioral
Standard of CareNoIntervention Group · 1 Intervention: Standard of Care · Intervention Types:
Time and Intensity-Match Control
Behavioral
ActiveComparator Group · 1 Intervention: Time-Matched Control (TM) · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: time frame: 6-month follow-up (approximately 6-months post quit date)

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,673 Previous Clinical Trials
30,828,296 Total Patients Enrolled
4 Trials studying Smoking, Cigarette
4,121 Patients Enrolled for Smoking, Cigarette
University of Texas at AustinOTHER
284 Previous Clinical Trials
65,939 Total Patients Enrolled
1 Trials studying Smoking, Cigarette
102 Patients Enrolled for Smoking, Cigarette
The Fenway InstituteOTHER
9 Previous Clinical Trials
1,897 Total Patients Enrolled
University of HoustonOTHER
123 Previous Clinical Trials
38,806 Total Patients Enrolled
2 Trials studying Smoking, Cigarette
210 Patients Enrolled for Smoking, Cigarette
Southern Methodist UniversityOTHER
33 Previous Clinical Trials
5,504 Total Patients Enrolled
Baylor College of MedicineOTHER
914 Previous Clinical Trials
5,981,679 Total Patients Enrolled
Jasper Smits, PhDPrincipal InvestigatorUniversity of Texas at Austin
4 Previous Clinical Trials
820 Total Patients Enrolled
Michael Zvolensky, PhDPrincipal InvestigatorUniversity of Houston
1 Previous Clinical Trials
150 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 5 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are HIV-positive.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 24th, 2021

Last Reviewed: October 28th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

Who else is applying?

What state do they live in?
Texas100.0%
How old are they?
18 - 65100.0%
What site did they apply to?
Thomas Street Health Center100.0%
What portion of applicants met pre-screening criteria?
Met criteria89.5%
Did not meet criteria10.5%
Why did patients apply to this trial?
  • "Maybe in hopes to find a cure to my tobacco addiction."
What questions have other patients asked about this trial?
  • "How long does the study take to complete?"
How many prior treatments have patients received?
0100.0%